Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

biospec pty ltd - chloropicrin - liquid - chloropicrin gas active 1600.0 g/l - vertebrate poison - rabbit burrow | rabbit warren - rabbit

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - chloropicrin - liquid - chloropicrin gas active 985.0 g/kg - mixed function pesticide - pre-planting soil treatment | rabbit burrow | soil heaps (under plastic or in drums) - bacteria | insect | nematode - soil borne plant parasitic | rabbit | soil borne fungi | weed seed | fat hen | prince of wales feather | weed seeds | winter grass

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - chloropicrin; 1,3-dichloropropene - liquid - chloropicrin gas active 333.0 g/kg; 1,3-dichloropropene solvent active 608.0 g/kg - mixed function pesticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - chloropicrin; 1,3-dichloropropene - liquid - chloropicrin gas active 795.0 g/kg; 1,3-dichloropropene solvent active 195.0 g/kg - mixed function pesticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - chloropicrin; 1,3-dichloropropene - emulsifiable concentrate - chloropicrin gas active 567.0 g/kg; 1,3-dichloropropene solvent active 371.0 g/kg - mixed function pesticide

United States - English - NLM (National Library of Medicine)

vero biotech, inc. - nitric oxide (unii: 31c4ky9esh) (nitric oxide - unii:31c4ky9esh) - genosyl ® is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. genosyl is contraindicated in neonates dependent on right-to-left shunting of blood. the safety and efficacy of nitric oxide for inhalation has been demonstrated in term and near-term neonates with hypoxic respiratory failure associated with evidence of pulmonary hypertension [see clinical studies (14.1)] . additional studies conducted in premature neonates for the prevention of bronchopulmonary dysplasia have not demonstrated substantial evidence of efficacy [see clinical studies (14.3)] . no information about its effectiveness in other age populations is available. nitric oxide is not indicated for use in the adult population.

United States - English - NLM (National Library of Medicine)

vero biotech, inc. - nitric oxide (unii: 31c4ky9esh) (nitric oxide - unii:31c4ky9esh) - genosyl® is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. genosyl is contraindicated in neonates dependent on right-to-left shunting of blood. the safety and efficacy of nitric oxide for inhalation has been demonstrated in term and near-term neonates with hypoxic respiratory failure associated with evidence of pulmonary hypertension [see clinical studies (14.1)] . additional studies conducted in premature neonates for the prevention of bronchopulmonary dysplasia have not demonstrated substantial evidence of efficacy [see clinical studies (14.3)] . no information about its effectiveness in other age populations is available. nitric oxide is not indicated for use in the adult population. vero biotech inc. 387 technology circle n